Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Transfusion ; 55(10): 2523-30, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26111254

RESUMO

China has entered a new phase in blood safety and availability through persistent efforts in the past decades. Based on national data from 2008 to 2012, we present a comprehensive review on the blood services ranging from policy and organization, supply, donors, screening and processing, and clinical use to government response in contemporary China. Current evidence suggests that the Chinese blood industries, after continual efforts in reforms on the legal framework and national management system, have been in a relatively steady but bottleneck stage. Although the blood industries have had an impressive track record on management and resolving problems, such as low availability, limited donors, deficient laboratory tests, shortage of blood products, and unnecessary clinical usage of blood still exist nationwide. While medical technology and services have seen a rapid increase in progress in recent years, they have not coordinated with the development of the national health care system. This article presents an analysis with detailed data, rich contents, and recent response from the Chinese government, allowing readers to appreciate how China, a country with more than 19.13% of the world's population, has long endeavored to improve safety and availability of blood. Meantime, the article sincerely welcomes the guidance on policymaking and technical assistance from the international community. Data in this article do not include those of Hong Kong, Macao, or Taiwan.


Assuntos
Doadores de Sangue/provisão & distribuição , Segurança do Sangue , Seleção do Doador , Segurança do Sangue/métodos , Segurança do Sangue/normas , Segurança do Sangue/tendências , China , Seleção do Doador/métodos , Seleção do Doador/organização & administração , Seleção do Doador/normas , Seleção do Doador/tendências , Humanos
2.
J Hered ; 103(6): 908-11, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22945945

RESUMO

GenScalpel is a program designed for the retrieval and extraction of specified sequences from large-scale sequence sets in NCBI GenBank flatfile format. This routine task in bioinformatics analysis is a pressing need for laboratory biologists. Another objective of application development is to respond to the new form of the NCBI Nucleotide Sequence Database, which was updated in November 2011. In addition to a powerful sequence refinement application, GenScalpel provides convenient functions for web-based sequence downloading or multiple files batch processing. This note discusses major applications of the program and includes example data sets to demonstrate its performance. The program is written in PERL. GenScalpel, including installation packages for Windows and Linux systems as well as the accompanying documentation, are available free of charge at http://genscalpel.biosv.com/.


Assuntos
Bases de Dados de Ácidos Nucleicos , Software , Análise de Sequência/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...